JenaValve Technology
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, JenaValve Technology sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).
JenaValve Technology: 4 sponsored US clinical trials, 2 recruiting.
JenaValve Technology sponsors 4 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting. The most-studied condition in this pipeline is Aortic Regurgitation, with 4 trials.
Upper-quartile sponsor footprint
JenaValve Technology sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
4 total, page 1 of 1
ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™
NCT06608823
The JenaValve ALIGN-AR LVAD Registry
NCT06594705
The JenaValve ALIGN-AR Pivotal Trial
NCT04415047
THE ALIGN-AR EFS TRIAL: JenaValve Pericardial TAVR Aortic Regurgitation Study
NCT02732704
Therapeutic Areas
What is open in the JenaValve Technology pipeline
2 recruiting of 4 indexed (50% open).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Aortic Regurgitation (4 trials), 4 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
JenaValve Technology: open-pipeline peers nationwide
Peers matched on 4 registered trials and 50% open enrollment, not the therapeutic-area sidebar.
JenaValve Technology sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 4 trials (± recruiting share)
- 4D pharma · 4 trials · 0% recruiting
- 60 Degrees Pharmaceuticals · 4 trials · 50% recruiting
- A2 Biotherapeutics · 4 trials · 75% recruiting
- Abdul Latif Jameel Poverty Action Lab · 4 trials · 25% recruiting
Sponsors near 50% open enrollment (± trial volume)
- 1200 Pharma · 50% recruiting · 2 trials
- 1ST Biotherapeutics · 50% recruiting · 2 trials
- 3ive Labs · 50% recruiting · 2 trials
- 7 Hills Pharma · 50% recruiting · 2 trials
Related
What to do with this JenaValve Technology page
4 registered trials is a research-attention snapshot, not an endorsement of JenaValve Technology or any single study.
- 2 of JenaValve Technology's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Aortic Regurgitation is the condition JenaValve Technology studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Aortic Regurgitation trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. JenaValve Technology pipeline card: 4 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.